Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma. [electronic resource]
Producer: 20160502Description: 2013-22 p. digitalISSN:- 1432-1335
- Adult
- Aged
- Antineoplastic Agents, Alkylating -- therapeutic use
- Antineoplastic Agents, Hormonal -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bendamustine Hydrochloride -- therapeutic use
- Blood Component Removal
- Bortezomib -- therapeutic use
- Disease-Free Survival
- Female
- Hematopoietic Stem Cell Mobilization -- adverse effects
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- therapy
- Prednisone -- therapeutic use
- Retrospective Studies
- Transplantation Conditioning
- Transplantation, Autologous -- adverse effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.